Skip to Content
Black Friday offer ends in

HER2-Positive Breast Cancer, 1st Edition

Authors :
Sara Hurvitz & Kelly McCann
Date of Publication: 08/2018
Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates ...view more

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.

Add to Cart

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.


Key Features
  • Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive.
  • Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations.
  • Includes a timely section on innovative future therapies.

Author Information
By Sara Hurvitz, MD and Kelly McCann